Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review

BACKGROUND AND AIM: Long-acting bronchodilators are the preferred option for maintenance therapy of patients with chronic obstructive pulmonary disease (COPD). The aim of this review is to provide an overview of the clinical studies evaluating the clinical efficacy of the once-daily fixed-dose dual...

Descripción completa

Detalles Bibliográficos
Autor principal: Ulrik, Charlotte Suppli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979690/
https://www.ncbi.nlm.nih.gov/pubmed/24729699
http://dx.doi.org/10.2147/COPD.S60362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979690/
https://www.ncbi.nlm.nih.gov/pubmed/24729699
http://dx.doi.org/10.2147/COPD.S60362

Ejemplares similares